Publications by authors named "Peter Probst"

Claim this Profile
S
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial.
Eric J Tarcha, Chelsea M Olsen, Peter Probst, David Peckham, Ernesto J Muñoz-Elías

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
Peter Probst, John B Grigg, Myra Wang, Ernesto Muñoz, Yueh-Ming Loo

Vaccine· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Krypton-81 in groundwater of the Culebra Dolomite near the Waste Isolation Pilot Plant, New Mexico.
Neil C Sturchio, Kristopher L Kuhlman, Reika Yokochi, Peter C Probst, Wei Jiang

J Contam Hydrol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.
Michelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, Anne-Rachel F Krostag, Kurt H Lustig, Peter Probst

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.
Christian Gerges, Mario Gerges, Marie B Lang, Yuhui Zhang, Johannes Jakowitsch, Peter Probst

Chest· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of atrial septal defect closure in adults: impact of age.
Michael Humenberger, Raphael Rosenhek, Harald Gabriel, Florian Rader, Maria Heger, Peter Probst

Eur Heart J· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
Yves-Laurent Bayard, Heyder Omran, Petr Neuzil, Leif Thuesen, Maximilian Pichler, Peter Probst

EuroIntervention· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Mariann Gyöngyösi, Günter Christ, Irene Lang, Gerhard Kreiner, Heinz Sochor, Peter Probst

JACC Cardiovasc Interv· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
Rhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, Peter Probst, Brenda Barth

FEMS Immunol Med Microbiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small vessel stenting with cobalt-chromium stents (Arthos Pico) in a real world setting.
Christoph Strehblow, Mariann Gyöngyösi, Gerald Zenker, Hubert Wallner, Matthias Heigert, Peter Probst

Coron Artery Dis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR4 agonists as immunomodulatory agents.
Mark R Alderson, Patrick McGowan, Jory R Baldridge, Peter Probst

J Endotoxin Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
Madeline M Fort, Afsaneh Mozaffarian, Axel G Stöver, Jean da Silva Correia, David A Johnson, Peter Probst

J Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis.
Ana L Gervassi, Kenneth H Grabstein, Peter Probst, Bruce Hess, Mark R Alderson

J Immunol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection.
Ana Gervassi, Mark R Alderson, Robert Suchland, Jean François Maisonneuve, Kenneth H Grabstein, Peter Probst

Infect Immun· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term clinical outcome after various stent implantation: overview of the results of uni- and multicenter stent registries.
Mariann Gyöngyösi, Aliashgar Khorsand, Wolfgang Sperker, Christoph Strehblow, Paul Wexberg, Peter Probst

Catheter Cardiovasc Interv· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?
Alexander Niessner, Stephan Hornykewycz, Senta Graf, Mariam Nikfardjam, Walter S Speidl, Peter Probst

Blood Coagul Fibrinolysis· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship of synthetic toll-like receptor 4 agonists.
Axel G Stöver, Jean Da Silva Correia, Jay T Evans, Christopher W Cluff, Mark W Elliott, Peter Probst

J Biol Chem· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of early reangiography within 30 days after coronary stenting.
Christine Scholten, Michael Schemper, Peter Probst, Gerald Maurer, Thomas Stefenelli

Can J Cardiol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans.
Ana L Gervassi, Peter Probst, Walter E Stamm, Jeanne Marrazzo, Kenneth H Grabstein

J Immunol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
Volker Schächinger, Christian W Hamm, Thomas Münzel, Michael Haude, Stephan Baldus, Peter Probst

J Am Coll Cardiol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Christoph W Kopp, Sabine Steiner, Ute Priglinger, Guenter Christ, Peter Probst

Blood Coagul Fibrinolysis· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.
Diana Bonderman, Alexander Teml, Johannes Jakowitsch, Christopher Adlbrecht, Mariann Gyöngyösi, Peter Probst

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis